ALLEGRO MICROSYSTEMS INC
For the period ended Jun 28, 2024. Filed Aug 2, 2024.
View on SEC.govAbout this filing
A company's report for each of its first three quarters. The financial statements are not audited. It shows how the business has moved since the last annual report, and what management says changed.
Jun 28, 2024 · Filed Aug 2, 2024
What changed in Risk Factors?
Read the current filingPrevious report: 10-Q
Period ended 2023-12-29; filed 2024-02-06.
0000950170-24-011712
Item 1A. Risk FactorsUnregistered Sales of Equity Securities and Use of ProceedsOther InformationCurrent report: 10-Q
Period ended 2024-06-28; filed 2024-08-02.
0000950170-24-089610
Item 1A. Risk FactorsUnregistered Sales of Equity Securities and Use of ProceedsOther InformationThe baseline is this issuer’s latest earlier reporting period of the same form that was filed before the current report. A previous 10-Q is a different quarter, not a year-over-year comparison. Amendments are excluded.
Compared 6 previous paragraphs and 6 current paragraphs.
4 unchanged; 1 reworded; 1 added; 1 removed; 0 previous and 0 current paragraphs rearranged.
Tables are not compared: 0 previous and 0 current tables excluded. Dates, whitespace, punctuation and numbering changes are ignored; changes to financial figures remain significant.
A changed paragraph is not evidence that risk increased or decreased. An unchanged paragraph does not establish that risk stayed the same.
Added paragraphs (1)
Current report
During the three-month period ended June 28, 2024, no director or officer of the Company adopted orterminated a “Rule 10b5-1 trading arrangement” or “non-Rule 10b5-1 trading arrangement” as each term is defined in Item 408(a) or Regulation S-K.
Removed paragraphs (1)
Previous report
On December 8, 2023, Mr. Max Glover, the Company’s Senior Vice President of Worldwide Sales, adopted a trading arrangement for the sale of shares of the Company’s common stock (a “Rule 10b5-1 Trading Plan”) that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c) under the Exchange Act. Mr. Glover’s Rule 10b5-1 Trading Plan, which terminates at the close of trading on December 31, 2024, for a total duration of 389 days, provides for the sale of up to 97,000 shares of common stock pursuant to the terms of the plan.
Reworded paragraphs (1)
Previous wording
Various risk factors associated with our business are included in our Annual Report, as filed with the SEC on May 21, 2023, and as supplemented by the additional risk factors included in our Quarterly Report on Form 10-Q for the quarterly period ended September 29, 2023, as filed with the SEC on November 6, 2023, each of which are available at www.sec.gov. There have been no material changes to those risk factors previously disclosed in our Annual Report, as supplemented by the risk factors included in our Quarterly Report on Form 10-Q for the quarterly period ended September 29, 2023.
Current wording
Various risk factors associated with our business are included in our Annual Report, as filed with the SEC on May 23, 2024, as supplemented by the risk factors included in the “Risk Factors” section of our Prospectus on Form S-3ASR dated July 23, 2024 and Prospectus Supplement on Form 424B5 dated July 23, 2024, which are available at www.sec.gov. There have been no material changes to those risk factors previously disclosed in our Annual Report, Prospectus and Prospectus Supplement.